Uroplasty, Inc. (UPI) Tops Q2 EPS by 2c
Tweet Send to a FriendGet Alerts UPI Hot Sheet
Price: $2.11 -1.86%
EPS Growth %: -66.7%
Financial Fact:
Research and development: 598.93K
Today's EPS Names:
CEDU, CHC, CIDM, More
EPS Growth %: -66.7%
Financial Fact:
Research and development: 598.93K
Today's EPS Names:
CEDU, CHC, CIDM, More
Trade UPI Now!
Uroplasty, Inc. (NASDAQ: UPI) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $5 million versus the consensus estimate of $4.93 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- John Wiley (JW-A) Misses Q4 EPS by 9c; Names New CFO; Updates on Restructuring
- WSI Industries, Inc. (WSCI) Reports Q3 EPS of $0.04
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
